Top Purchases
The top purchases made by insiders yesterday. Remember, returns and win rates are calculated using the previous purchase trades by the insider.
Director at Nuvation Bio Inc. ($NUVB)
The Director purchased 172,189 shares at $2.90/share ($500K total) which increased their vested holdings by 0.0%. The current price is $2.99 (+3.0%). Their median purchase size is $1.25M and this is their 4th largest purchase out of 4 all time. (SEC Source)
Historic Returns
1m returns: 11% weighted | 9% median | 67% win rate (2/3)
3m returns: 113% weighted | 31% median | 67% win rate (2/3)
6m returns: 408% weighted | 187% median | 67% win rate (2/3)
1y returns: 908% weighted | 1521% median | 67% win rate (2/3)
CEO at Perspective Therapeutics, Inc. ($CATX)
The CEO purchased 100,000 shares at $1.17/share ($117K total) which increased their vested holdings by 93.0%. The current price is $1.16 (-1.2%). Their median purchase size is $83,699.40 and this is their 1st largest purchase out of 2 all time. (SEC Source)
Historic Returns
1m returns: 68% weighted | 68% median | 100% win rate (1/1)
3m returns: 96% weighted | 96% median | 100% win rate (1/1)
6m returns: 19% weighted | 19% median | 100% win rate (1/1)
1y returns: -21% weighted | -21% median | 0% win rate (0/1)
Chief Executive Officer at GXO Logistics, Inc. ($GXO)
The Chief Executive Officer purchased 10,000 shares at $49.95/share ($500K total) which increased their vested holdings by 11.0%. The current price is $49.44 (-1.0%). Their median purchase size is $342K and this is their 1st largest purchase out of 2 all time. (SEC Source)
Historic Returns
1m returns: 0% weighted | 0% median | 100% win rate (1/1)
3m returns: 12% weighted | 12% median | 100% win rate (1/1)
6m returns: 30% weighted | 30% median | 100% win rate (1/1)
1y returns: 28% weighted | 28% median | 100% win rate (1/1)
Top Sales
The top sales made by insiders yesterday. Remember, returns and win rates are calculated using the previous sell trades by the insider. For sell transactions, “win rate” is the percent of profitable trades. If the “win rate” is low, that means the stock typically falls after the insider sells.
10% Owner at Samsara Inc. ($IOT)
The 10% Owner sold 277,484 shares at $28.88/share ($8.01M total) which decreased their vested holdings by 0.3%. The current price is $28.60 (-1.0%). Their median sale size is $8.01M and this is their 3rd largest sale out of 5 all time. (SEC Source)
Historic Returns
1m returns: -23% weighted | -15% median | 0% win rate (0/4)
3m returns: -30% weighted | -13% median | 50% win rate (2/4)
6m returns: -24% weighted | -15% median | 25% win rate (1/4)
1y returns: -57% weighted | -57% median | 0% win rate (0/3)
Note: 5 other insiders also sold the stock
Director at HALOZYME THERAPEUTICS, INC. ($HALO)
The Director sold 20,000 shares at $50.31/share ($1.01M total) which decreased their vested holdings by 16.7%. The current price is $49.62 (-1.4%). Their median sale size is $1.36M and this is their 2nd largest sale out of 2 all time. (SEC Source)
Historic Returns
1m returns: -4% weighted | -4% median | 0% win rate (0/1)
3m returns: -19% weighted | -19% median | 0% win rate (0/1)
6m returns: -40% weighted | -40% median | 0% win rate (0/1)
1y returns: -29% weighted | -29% median | 0% win rate (0/1)
Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.
